Related Experiment Video
Updated: Jul 10, 2026

28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Newer pathologic assessment techniques for colorectal carcinoma
Roderick R Turner1, Carolyn Li, Carolyn C Compton
1Department of Pathology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA. r.turner@stjohns.org
Summary
Colorectal carcinoma progression involves genetic changes impacting cell behavior. Research focuses on new markers, including molecular tests and improved pathology, to enhance cancer prognosis and patient treatment strategies.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Colorectal carcinoma pathogenesis involves progressive genetic abnormalities leading to malignant phenotypes.
- Histopathologic features like tumor stage and grade are crucial for patient management.
- There is a need for additional markers to improve prognostic and predictive accuracy in colorectal cancer analysis.
Purpose of the Study:
- To review promising advancements in colorectal cancer diagnostics.
- To discuss novel markers for enhancing prognostic and predictive power.
- To explore the clinical utility of new molecular and histopathologic approaches.
Main Methods:
- Review of recent research on histopathologic evaluation, lymph node staging, and molecular analysis.
- Analysis of genotypic studies (microsatellite instability, chromosome 18q deletion).
- Evaluation of immunophenotypic studies (gene expression, proliferation, angiogenesis) and microarray techniques.
Main Results:
- Histopathologic improvements are needed for standardized grading and recognizing tumor budding.
- Genotypic and immunophenotypic studies offer insights into tumor biology and behavior.
- Microarray techniques show potential for subtyping microsatellite-stable colorectal carcinoma.
Conclusions:
- Advancements in histopathology, lymph node staging, and molecular analysis hold significant promise for colorectal cancer management.
- Standardizing histologic grade and identifying tumor budding are critical.
- Molecular subtyping may lead to personalized prognostic and therapeutic strategies for colorectal cancer patients.

